Trial Profile
Efficacy of Aripiprazole in Combination With Lithium or Valproate in the Long-Term Maintenance Treatment of Bipolar I Disorder in Outpatients Partially Nonresponsive to Lithium or Valproate Monotherapy.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Apr 2023
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary) ; Lithium (Primary) ; Valproic acid (Primary)
- Indications Bipolar I disorders
- Focus Registrational; Therapeutic Use
- Sponsors Otsuka Pharmaceutical Development & Commercialization
- 08 Apr 2011 Trade name Abilify identified from ClinicalTrials.gov.
- 08 Apr 2011 According to ClinicalTrials.gov actual patients recruited 1270.
- 01 Mar 2011 Results published in the Bipolar Disorders.